Moffitt Researchers Identify Tumor-Based Methylation Patterns as Cancer Biomarkers
In a new study featured on the cover of the May 1 issue of the journal Cancer Research, Moffitt Cancer Center researchers report on their identification of biomarkers based on a type of genetic modification called methylation that predicts the type...
18-May-2022 8:05 AM EDT
Add to Favorites
Moffitt Researchers Identify Pathway that Regulates Lipid Synthesis and Contributes to Tumor Survival
In a new study published in the journal Cell Reports, Moffitt Cancer Center researchers show that cancer cells in an acidic environment undergo lipid synthesis and accumulation. The team identified the key signaling molecules responsible for these...
10-May-2022 11:20 AM EDT
Add to Favorites
Moffitt Researchers Identify Key Factors Impacting Adaptive Therapy
Researchers in the Center of Excellence for Evolutionary Therapy at Moffitt Cancer Center have been investigating an alternative treatment approach called adaptive therapy that focuses on maintaining disease control instead of complete tumor cell...
9-May-2022 11:25 AM EDT
Add to Favorites
Moffitt Researchers Discover New Target for CAR T Cells in Solid Tumors
In a new study published in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research, Moffitt Cancer Center researchers share the identification of a new potential target for CAR T cells called OR2H1 that they have...
4-May-2022 10:05 AM EDT
Add to Favorites
Moffitt Researchers Develop Model to Predict Patients with Poor Lung Cancer Outcomes
Moffitt Cancer Center researchers are working to improve the ability to identify patients who are at a higher risk of poor survival through radiomics, an area of science that uses imaging, such as CT scans and MRIs, to uncover tumoral patterns and...
27-Apr-2022 9:40 AM EDT
Add to Favorites
Moffitt Researchers Identify Key Characteristics of Immune Cells in Ovarian Cancer
Researchers at Moffitt Cancer Center want to improve their understanding of the immune environment in ovarian cancer in hopes of making immunotherapy an option for these patients. In a new study published in Cancer Cell, they report on key...
14-Apr-2022 11:00 AM EDT
Add to Favorites
Moffitt Researchers Identify Immunosuppression as a Key Factor Leading to Colorectal Cancer Development
Moffitt Cancer Center researchers have revealed that the creation of an immunosuppressive environment is key to the progression of benign colorectal adenomas to invasive, malignant carcinomas. Their findings were published in Nature Communications.
7-Apr-2022 9:00 AM EDT
Add to Favorites
SpaceX to Take Moffitt Investigators’ Experiment to the International Space Station
Drs. Patsy McDonald and Derek Duckett, Moffitt Cancer Center faculty members and founders of Cadw Therapeutics, are sending a scientific experiment to space. The self-contained experiment will blast off Wednesday, April 6, as a part of Axiom...
30-Mar-2022 10:00 AM EDT
Add to Favorites
See All News
CANCER AND COVID-19: Moffitt Cancer Center Experts & Resources
1-Apr-2020 8:40 AM EDT
Moffitt Cancer Center HPV Expert Kicked Off EUROGIN Conference
Anna Giuliano, Ph.D., director of Moffitt Cancer Center’s Center for Infection Research in Cancer, delivered the opening keynote address at the 2017 European Research Organization on Genital Infection and Neoplasia (EUROGIN) International...
10-Oct-2017 10:05 AM EDT